Exchange: NASDAQ·Updated 07:55 PM EST
VYNE logo

VYNE VYNE Therapeutics Inc

$13.93
$4.10
(22.74%)
Today
Closed $13.93
$0.27
(1.94%)
After Hours
Mkt Cap$170.16M
Vol264,839.00

About VYNE

Yarrow Bioscience, Inc. is a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases. The company is developing YB-101, a potentially first-of-its-kind antibody therapy aimed at treating Graves disease (GD) and thyroid eye disease (TED). Yarrow Bioscience was founded in October 2025 and is headquartered in New Haven, CT.
45

Neutral Sentiment

How do you feel about VYNE?

hiTHit
$VYNE Honest thieves no longer come to our place because there's nothing left to steal here.

Advertisement|Remove ads.